Athersys, Inc. (ATHX:NASDAQ) rocketted at $0.86, representing a gain of 63%. On Fri, Apr 08, 2022, ATHX:NASDAQ touched a New 2-Week Low of $0.53. The stock appeared on our News Catalysts scanner on Mon, Apr 04, 2022 at 12:55 PM in the 'BIOTECH' category. From Fri, Mar 25, 2022, the stock recorded 10.00% Up Days and 9.09% Green Days
The stock spiked on Wed, Feb 02, 2022 at $1.06 with a volume of 2M+.
About Athersys, Inc. (ATHX:NASDAQ)
Athersys Inc is a biopharmaceutical company engaged in the discovery and development of therapeutic product candidates designed to extend and improve the quality of human life.
Top 10 Gainers:
- Veru Inc. (VERU:NASDAQ), 182.3%
- Hoth Therapeutics, Inc. (HOTH:NASDAQ), 71.57%
- Athersys, Inc. (ATHX:NASDAQ), 63%
- Altamira Therapeutics Ltd. (CYTO:NASDAQ), 55.14%
- Genocea Biosciences, Inc. (GNCA:NASDAQ), 50%
- Kintara Therapeutics Inc. (KTRA:NASDAQ), 35.41%
- 21Vianet Group, Inc. (VNET:NASDAQ), 29.63%
- SailPoint Technologies Holdings, Inc. (SAIL:NYSE), 29.16%
- Reading International, Inc. (RDIB:NASDAQ), 25.54%
- 5E Advanced Materials Inc. (FEAM:NASDAQ), 24%